26 results on '"Rea F"'
Search Results
2. Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors
3. 119P Evolution of the management of stage III non-small cell lung cancer (NSCLC): A single-center real-world scenario over 10 years
4. 105P A model of workflow for radiomics signature of stage III non-small cell lung cancer (NSCLC) patients (pts)
5. 1157P Diagnostic therapeutic pathway (DTP) of early stage non-small cell lung cancer (eNSCLC): A real-world focus on EGFR status detection in resected patients (pts)
6. 1221P Surgically resected superior sulcus (SS) non-small cell lung cancer (NSCLC) after induction chemo (C)- and radiotherapy (R): A focus on the immune microenvironment (IM)
7. The surgeon and the oncologist in non-small cell lung cancer (NSCLC)
8. Immune microenvironment modulation by p14/ARF in malignant pleural mesothelioma
9. Combined immunoscore for prognostic stratification of early stage NSCLC patients
10. The role of surgery in integrated therapies for non-small-cell lung cancer
11. Updated report of an observational clinical registry (REGCLIN-MM) on malignant pleural mesothelioma (MPM)
12. Surgery in multimodal management in non-metastatic small cell lung cancer: a retrospective monocentric series
13. Malignant pleural mesothelioma immune microenvironment and checkpoint expression before and after systemic cytotoxic treatment
14. Thymoma and thymic carcinoma: A real-life retrospective analysis
15. 1850P - Immune microenvironment modulation by p14/ARF in malignant pleural mesothelioma
16. 1454P - Combined immunoscore for prognostic stratification of early stage NSCLC patients
17. E23 - Surgery in multimodal management in non-metastatic small cell lung cancer: a retrospective monocentric series
18. E17 - Updated report of an observational clinical registry (REGCLIN-MM) on malignant pleural mesothelioma (MPM)
19. 1619PD - Malignant pleural mesothelioma immune microenvironment and checkpoint expression before and after systemic cytotoxic treatment
20. 166P - Thymoma and thymic carcinoma: A real-life retrospective analysis
21. An Exploratory Phase 2 Study of Pemetrexed (Pem) and Cisplatin (Cis) As Preoperative Chemotherapy (Ct) in the Treatment of Stage Iiian2 Nonsquamous Non-Small Cell Lung Cancer (Ns Nsclc)
22. Carboplatin, Paclitaxel and Gemcitabine As Induction Treatment Followed By Surgery and/or Radiotherapy: an Exploratory Analysis in Locally-Advanced Non-Small Cell Lung Cancer (Nsclc)
23. Gtf2I Mutations are Frequent in Thymic Epithelial Tumors
24. 1557PD - Gtf2I Mutations are Frequent in Thymic Epithelial Tumors
25. 1201P - Carboplatin, Paclitaxel and Gemcitabine As Induction Treatment Followed By Surgery and/or Radiotherapy: an Exploratory Analysis in Locally-Advanced Non-Small Cell Lung Cancer (Nsclc)
26. 1203P - An Exploratory Phase 2 Study of Pemetrexed (Pem) and Cisplatin (Cis) As Preoperative Chemotherapy (Ct) in the Treatment of Stage Iiian2 Nonsquamous Non-Small Cell Lung Cancer (Ns Nsclc)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.